{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:13:33Z","timestamp":1705018413701},"reference-count":34,"publisher":"RCN Publishing Ltd.","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,7]]},"DOI":"10.7748\/ncyp.2023.e1458","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T10:30:23Z","timestamp":1675852223000},"page":"14-21","source":"Crossref","is-referenced-by-count":0,"title":["Respiratory syncytial virus and its prophylaxis with palivizumab: exploring nurses\u2019 knowledge"],"prefix":"10.7748","volume":"35","author":[{"given":"Eilish","family":"Moore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4499","published-online":{"date-parts":[[2023,2,8]]},"reference":[{"issue":"2","key":"key20230906114941_R1","doi-asserted-by":"crossref","first-page":"e620","DOI":"10.1542\/peds.2014-1666","article-title":"Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection","volume":"134","author":"American Academy of Pediatrics Committee on Infectious Diseases, American Academy of Pediatrics Bronchiolitis Guidelines Committee","year":"2014","journal-title":"Pediatrics"},{"key":"key20230906114941_R2","first-page":"195","article-title":"Compliance with RSV prophylaxis: global physicians\u2019 perspectives","volume":"3","year":"2009","journal-title":"Patient Preference and Adherence"},{"issue":"6","key":"key20230906114941_R3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1891\/0730-0832.31.6.369","article-title":"Identifying and ensuring optimal care for all children at risk of developing serious respiratory syncytial virus disease: a Canadian nurses\u2019 perspective","volume":"31","year":"2012","journal-title":"Neonatal Network"},{"issue":"2","key":"key20230906114941_R4","doi-asserted-by":"crossref","first-page":"NP1","DOI":"10.1177\/2150135119830271","article-title":"Palivizumab compliance in the cardiac care unit. Selected abstracts from Cardiology 2019: 22nd Annual Update on Pediatric and Congenital Cardiovascular Disease. Huntington Beach, California \u2013 February 13-17, 2019","volume":"10","year":"2019","journal-title":"World Journal for Pediatric and Congenital Heart Surgery"},{"issue":"5","key":"key20230906114941_R5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.5863\/1551-6776-22.5.338","article-title":"Improving palivizumab compliance through a pharmacist-managed RSV prevention clinic","volume":"22","year":"2017","journal-title":"Journal of Pediatric Pharmacology and Therapeutics"},{"key":"key20230906114941_R6","unstructured":"Data Protection Commission (2023) For Organisations: Know Your Obligations. dataprotection.ie\/en\/organisations\/know-your-obligations\/data-security-guidance (Last accessed: 9 January 2023.)"},{"issue":"4","key":"key20230906114941_R7","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1067\/S0022-3476(03)00454-2","article-title":"Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease","volume":"143","year":"2003","journal-title":"Journal of Pediatrics"},{"issue":"1","key":"key20230906114941_R8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.18553\/jmcp.2010.16.1.46","article-title":"A systematic review of compliance with palivizumab administration for RSV immunoprophylaxis","volume":"16","year":"2010","journal-title":"Journal of Managed Care Pharmacy"},{"key":"key20230906114941_R9","unstructured":"Health Protection Surveillance Centre (2021) Influenza Surveillance in Ireland \u2013 Weekly Report. Influenza Week 4 2021 (25th-31st January 2021). hpsc.ie\/a-z\/respiratory\/influenza\/seasonalinfluenza\/surveillance\/influenzasurveillancereports\/previousinfluenzaseasonssurveillancereports\/20202021season\/Influenza_Surveillance_Report_Week%204%202021_FINAL.pdf (Last accessed: 9 January 2023.)"},{"key":"key20230906114941_R10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/1471-2431-14-261","article-title":"Partial palivizumab prophylaxis and increased risk of hospitalization due to respiratory syncytial virus in a Medicaid population: a retrospective cohort analysis","volume":"14","year":"2014","journal-title":"BMC Pediatrics"},{"issue":"3","key":"key20230906114941_R11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/thoraxjnl-2019-213764","article-title":"Geospatial and seasonal variation of bronchiolitis in England: a cohort study using hospital episode statistics","volume":"75","year":"2020","journal-title":"Thorax"},{"issue":"7","key":"key20230906114941_R12","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1542\/hpeds.2019-0026","article-title":"Pediatric inpatient immunizations: a literature review","volume":"9","year":"2019","journal-title":"Hospital Pediatrics"},{"issue":"15","key":"key20230906114941_R13","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1055\/s-0041-1725146","article-title":"Respiratory syncytial virus immunoprophylaxis with palivizumab: 12-year observational study of usage and outcomes in Canada","volume":"39","year":"2022","journal-title":"American Journal of Perinatology"},{"issue":"9725","key":"key20230906114941_R14","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis","volume":"375","year":"2010","journal-title":"The Lancet"},{"key":"key20230906114941_R15","first-page":"917068","article-title":"Respiratory-related hospitalizations following prophylaxis in the Canadian registry for palivizumab (2005-2012) compared to other international registries","volume":"2013","year":"2013","journal-title":"Clinical & Developmental Immunology"},{"key":"key20230906114941_R16","volume-title":"Nursing Research: Principles, Process and Issues","year":"2014","edition":"Third edition"},{"issue":"1","key":"key20230906114941_R17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/jpc.14491","article-title":"Ten years of severe respiratory syncytial virus infections in a tertiary paediatric intensive care unit","volume":"56","year":"2020","journal-title":"Journal of Paediatrics and Child Health"},{"issue":"2","key":"key20230906114941_R18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.aenj.2013.12.003","article-title":"Opportunistic immunisation in the emergency department: a survey of staff knowledge, opinion and practices","volume":"17","year":"2014","journal-title":"Australasian Emergency Nursing Journal"},{"key":"key20230906114941_R19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.puhe.2020.01.006","article-title":"Parent and staff attitudes towards in-hospital opportunistic vaccination","volume":"182","year":"2020","journal-title":"Public Health"},{"key":"key20230906114941_R20","volume-title":"Nursing Research: Generating and Assessing Evidence for Nursing Practice","year":"2017","edition":"Tenth edition"},{"issue":"9","key":"key20230906114941_R21","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1542\/hpeds.2015-0112","article-title":"Missed opportunities for influenza vaccination among hospitalized children with influenza at a tertiary care facility","volume":"6","year":"2016","journal-title":"Hospital Pediatrics"},{"issue":"3","key":"key20230906114941_R22","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/irv.12482","article-title":"Exploring provider and parental perceptions to influenza vaccination in the inpatient setting","volume":"12","year":"2018","journal-title":"Influenza and Other Respiratory Viruses"},{"issue":"9","key":"key20230906114941_R23","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1080\/21645515.2017.1337614","article-title":"Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection","volume":"13","year":"2017","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"6","key":"key20230906114941_R24","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s10096-016-2891-6","article-title":"Respiratory syncytial virus associated hospitalizations in preterm infants of 29 to 32 weeks gestational age using a risk score tool for palivizumab prophylaxis","volume":"36","year":"2017","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"issue":"2","key":"key20230906114941_R25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pedhc.2018.08.003","article-title":"Infant immunizations in pediatric critical care: a quality improvement project","volume":"33","year":"2019","journal-title":"Journal of Pediatric Health Care"},{"issue":"1","key":"key20230906114941_R26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/1527154420965543","article-title":"Respiratory syncytial virus disease: immunoprophylaxis policy review and public health concerns in preterm and young infants","volume":"22","year":"2021","journal-title":"Policy, Politics & Nursing Practice"},{"key":"key20230906114941_R27","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/1471-2334-13-334","article-title":"Association of RSV-related hospitalization and non-compliance with palivizumab among commercially insured infants: a retrospective claims analysis","volume":"13","year":"2013","journal-title":"BMC Infectious Diseases"},{"issue":"3 Pt 1","key":"key20230906114941_R28","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1542\/peds.102.3.531","article-title":"Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants","volume":"102","author":"The IMpact-RSV Study Group","year":"1998","journal-title":"Pediatrics"},{"key":"key20230906114941_R29","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1017\/S1047951117000609","article-title":"CHD and respiratory syncytial virus: global expert exchange recommendations","volume":"27","year":"2017","journal-title":"Cardiology in the Young"},{"key":"key20230906114941_R30","unstructured":"UK Health Security Agency (2015) Respiratory Syncytial Virus. The Green Book Chapter 27a. assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/458469\/Green_Book_Chapter_27a_v2_0W.PDF (Last accessed: 9 January 2023.)"},{"key":"key20230906114941_R31","doi-asserted-by":"crossref","first-page":"120","DOI":"10.12688\/wellcomeopenres.16778.2","article-title":"Study pre-protocol for \u2018BronchStart \u2013 the impact of the COVID-19 pandemic on the timing, age and severity of respiratory syncytial virus (RSV) emergency presentations; a multi-centre prospective observational cohort study\u2019","volume":"6","year":"2022","journal-title":"Wellcome Open Research"},{"issue":"1298","key":"key20230906114941_R32","first-page":"8","article-title":"Immunisation in hospital: an opportunity repeatedly missed","volume":"122","year":"2009","journal-title":"New Zealand Medical Journal"},{"issue":"13","key":"key20230906114941_R33","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1177\/0009922815621343","article-title":"The logistics and coordination of respiratory syncytial virus immunoprophylaxis use among US pediatric specialists","volume":"55","year":"2016","journal-title":"Clinical Pediatrics"},{"issue":"1","key":"key20230906114941_R34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/17476348.2018.1401926","article-title":"Adherence and outcomes: a systematic review of palivizumab utilization","volume":"12","year":"2018","journal-title":"Expert Review of Respiratory Medicine"}],"container-title":["Nursing Children and Young People"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.rcni.com\/doi\/pdf\/10.7748\/ncyp.2023.e1458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T19:44:01Z","timestamp":1705002241000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.rcni.com\/doi\/10.7748\/ncyp.2023.e1458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,8]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,2,8]]},"published-print":{"date-parts":[[2023,9,7]]}},"alternative-id":["10.7748\/ncyp.2023.e1458"],"URL":"https:\/\/doi.org\/10.7748\/ncyp.2023.e1458","relation":{},"ISSN":["2046-2336","2046-2344"],"issn-type":[{"value":"2046-2336","type":"print"},{"value":"2046-2344","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,8]]}}}